These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Smolen JS; Braun J; Dougados M; Emery P; Fitzgerald O; Helliwell P; Kavanaugh A; Kvien TK; Landewé R; Luger T; Mease P; Olivieri I; Reveille J; Ritchlin C; Rudwaleit M; Schoels M; Sieper J; Wit Md; Baraliakos X; Betteridge N; Burgos-Vargas R; Collantes-Estevez E; Deodhar A; Elewaut D; Gossec L; Jongkees M; Maccarone M; Redlich K; van den Bosch F; Wei JC; Winthrop K; van der Heijde D Ann Rheum Dis; 2014 Jan; 73(1):6-16. PubMed ID: 23749611 [TBL] [Abstract][Full Text] [Related]
5. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update. Stoffer MA; Schoels MM; Smolen JS; Aletaha D; Breedveld FC; Burmester G; Bykerk V; Dougados M; Emery P; Haraoui B; Gomez-Reino J; Kvien TK; Nash P; Navarro-Compán V; Scholte-Voshaar M; van Vollenhoven R; van der Heijde D; Stamm TA Ann Rheum Dis; 2016 Jan; 75(1):16-22. PubMed ID: 25990290 [TBL] [Abstract][Full Text] [Related]
6. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Smolen JS; Landewé R; Bijlsma J; Burmester G; Chatzidionysiou K; Dougados M; Nam J; Ramiro S; Voshaar M; van Vollenhoven R; Aletaha D; Aringer M; Boers M; Buckley CD; Buttgereit F; Bykerk V; Cardiel M; Combe B; Cutolo M; van Eijk-Hustings Y; Emery P; Finckh A; Gabay C; Gomez-Reino J; Gossec L; Gottenberg JE; Hazes JMW; Huizinga T; Jani M; Karateev D; Kouloumas M; Kvien T; Li Z; Mariette X; McInnes I; Mysler E; Nash P; Pavelka K; Poór G; Richez C; van Riel P; Rubbert-Roth A; Saag K; da Silva J; Stamm T; Takeuchi T; Westhovens R; de Wit M; van der Heijde D Ann Rheum Dis; 2017 Jun; 76(6):960-977. PubMed ID: 28264816 [TBL] [Abstract][Full Text] [Related]
7. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Smolen JS; Landewé RBM; Bijlsma JWJ; Burmester GR; Dougados M; Kerschbaumer A; McInnes IB; Sepriano A; van Vollenhoven RF; de Wit M; Aletaha D; Aringer M; Askling J; Balsa A; Boers M; den Broeder AA; Buch MH; Buttgereit F; Caporali R; Cardiel MH; De Cock D; Codreanu C; Cutolo M; Edwards CJ; van Eijk-Hustings Y; Emery P; Finckh A; Gossec L; Gottenberg JE; Hetland ML; Huizinga TWJ; Koloumas M; Li Z; Mariette X; Müller-Ladner U; Mysler EF; da Silva JAP; Poór G; Pope JE; Rubbert-Roth A; Ruyssen-Witrand A; Saag KG; Strangfeld A; Takeuchi T; Voshaar M; Westhovens R; van der Heijde D Ann Rheum Dis; 2020 Jun; 79(6):685-699. PubMed ID: 31969328 [TBL] [Abstract][Full Text] [Related]
8. Rheumatoid arthritis: 2014 treat-to-target RA recommendations--strategy is key. Huizinga T; Knevel R Nat Rev Rheumatol; 2015 Sep; 11(9):509-11. PubMed ID: 26195337 [TBL] [Abstract][Full Text] [Related]
9. Treat to target strategy in rheumatoid arthritis: real benefits. Cardiel MH Reumatol Clin; 2013; 9(2):101-5. PubMed ID: 22985804 [TBL] [Abstract][Full Text] [Related]
10. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Smolen JS; Landewé R; Breedveld FC; Dougados M; Emery P; Gaujoux-Viala C; Gorter S; Knevel R; Nam J; Schoels M; Aletaha D; Buch M; Gossec L; Huizinga T; Bijlsma JW; Burmester G; Combe B; Cutolo M; Gabay C; Gomez-Reino J; Kouloumas M; Kvien TK; Martin-Mola E; McInnes I; Pavelka K; van Riel P; Scholte M; Scott DL; Sokka T; Valesini G; van Vollenhoven R; Winthrop KL; Wong J; Zink A; van der Heijde D Ann Rheum Dis; 2010 Jun; 69(6):964-75. PubMed ID: 20444750 [TBL] [Abstract][Full Text] [Related]
11. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Smolen JS; Schöls M; Braun J; Dougados M; FitzGerald O; Gladman DD; Kavanaugh A; Landewé R; Mease P; Sieper J; Stamm T; Wit M; Aletaha D; Baraliakos X; Betteridge N; Bosch FVD; Coates LC; Emery P; Gensler LS; Gossec L; Helliwell P; Jongkees M; Kvien TK; Inman RD; McInnes IB; Maccarone M; Machado PM; Molto A; Ogdie A; Poddubnyy D; Ritchlin C; Rudwaleit M; Tanew A; Thio B; Veale D; Vlam K; van der Heijde D Ann Rheum Dis; 2018 Jan; 77(1):3-17. PubMed ID: 28684559 [TBL] [Abstract][Full Text] [Related]
12. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Smolen JS; Landewé RBM; Bergstra SA; Kerschbaumer A; Sepriano A; Aletaha D; Caporali R; Edwards CJ; Hyrich KL; Pope JE; de Souza S; Stamm TA; Takeuchi T; Verschueren P; Winthrop KL; Balsa A; Bathon JM; Buch MH; Burmester GR; Buttgereit F; Cardiel MH; Chatzidionysiou K; Codreanu C; Cutolo M; den Broeder AA; El Aoufy K; Finckh A; Fonseca JE; Gottenberg JE; Haavardsholm EA; Iagnocco A; Lauper K; Li Z; McInnes IB; Mysler EF; Nash P; Poor G; Ristic GG; Rivellese F; Rubbert-Roth A; Schulze-Koops H; Stoilov N; Strangfeld A; van der Helm-van Mil A; van Duuren E; Vliet Vlieland TPM; Westhovens R; van der Heijde D Ann Rheum Dis; 2023 Jan; 82(1):3-18. PubMed ID: 36357155 [TBL] [Abstract][Full Text] [Related]
13. Update of French society for rheumatology recommendations for managing rheumatoid arthritis. Daien C; Hua C; Gaujoux-Viala C; Cantagrel A; Dubremetz M; Dougados M; Fautrel B; Mariette X; Nayral N; Richez C; Saraux A; Thibaud G; Wendling D; Gossec L; Combe B Joint Bone Spine; 2019 Mar; 86(2):135-150. PubMed ID: 30315988 [TBL] [Abstract][Full Text] [Related]
14. Challenges in implementing treat-to-target in rheumatoid arthritis: a perspective from Brazilian rheumatologists. Kakehasi AM; Duarte ALBP; Brenol CV; Domiciano DS; Laurindo IMM; Bonfiglioli KR; da Mota LMH; Buch MH; de Almeida Macêdo E; Xavier RM Adv Rheumatol; 2024 Aug; 64(1):63. PubMed ID: 39187901 [TBL] [Abstract][Full Text] [Related]
15. Treat-to-target in rheumatoid arthritis: Evaluating the patient perspective using the Patient Opinion Real-Time Anonymous Liaison system: The RA T2T PORTAL study. Benham H; Rutherford M; Kirby S; Stebbings S; White D; Sim D; Harrison A Int J Rheum Dis; 2019 May; 22(5):874-879. PubMed ID: 30793870 [TBL] [Abstract][Full Text] [Related]
17. EULAR definition of difficult-to-treat rheumatoid arthritis. Nagy G; Roodenrijs NMT; Welsing PM; Kedves M; Hamar A; van der Goes MC; Kent A; Bakkers M; Blaas E; Senolt L; Szekanecz Z; Choy E; Dougados M; Jacobs JW; Geenen R; Bijlsma HW; Zink A; Aletaha D; Schoneveld L; van Riel P; Gutermann L; Prior Y; Nikiphorou E; Ferraccioli G; Schett G; Hyrich KL; Mueller-Ladner U; Buch MH; McInnes IB; van der Heijde D; van Laar JM Ann Rheum Dis; 2021 Jan; 80(1):31-35. PubMed ID: 33004335 [TBL] [Abstract][Full Text] [Related]
18. Treating rheumatoid arthritis to target: the patient version of the international recommendations. de Wit MP; Smolen JS; Gossec L; van der Heijde DM Ann Rheum Dis; 2011 Jun; 70(6):891-5. PubMed ID: 21478190 [TBL] [Abstract][Full Text] [Related]